Capital Change Notice for Bridging Capital Placement

Capital Change Notice




Section 1: Issuer information
Name of issuer Rua Bioscience Limited
NZX ticker code RUA
Class of financial product Ordinary Shares
ISIN (If unknown, check on NZX website) NZRUAE0004S1
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 3,968,254
Nominal value (if any) NA
Issue/acquisition/redemption price per security $0.0378
Nature of the payment (for example, cash or other
consideration)
Cash comprising total
proceeds of $150,000
Amount paid up (if not in full) Fully paid
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of
Financial Products of the Class, excluding any Treasury Stock,
in existence)
1

2.48% of the total number of
Ordinary Shares on issue.
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or the
Option (for example, the exercise price and exercise date)
NA
Reason for issue/acquisition/redemption and specific authority
for issue/acquisition/redemption/ (the reason for change must
be identified here)
Issue of ordinary shares under
a placement announce on 20
September 2024 to fund short-
term working capital
requirements and authorised
by a Board resolution on 19
September 2024.
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury
Stock) and the total number of Financial Products of the Class
held as Treasury Stock after the issue/acquisition/redemption.
163, 718, 833
In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
NA
Specific authority for the issue, acquisition, or redemption,
including a reference to the rule pursuant to which the issue,
acquisition, or redemption is made
Authorised by a resolution of
the Board. The placement is
made pursuant to NZX Listing
Rule 4.5.1 and authorised by
Board resolution dated 19
September 2024.

1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
Issue of ordinary shares which
rank equally with all other fully
paid shares in Rua Bioscience
Limited
Date of issue/acquisition/redemption
2
23
rd
September 2024
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement Paul Naske
Contact person for this announcement Paul Naske
Contact phone number +64 21 445154
Contact email address paul.naske@ruabio.com
Date of release through MAP

24
th
September 2024




2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).

---

24
th
September 2024


FOR PUBLIC RELEASE

Capital Change Notice
Rua Bisocience Limited (NZX: RUA) provides the attached Capital Change Notice pursuant to NZX Listing Rule
3.17. This notice relates to the issue of 3,968,254 ordinary shares under the placement announced on 20
th

September 2024 (the Placement).
For the purposes of NZX Listing Rule 4.17.9(c), Rua’s objectives for allocations under the Placement were
primarily to ensure short term funding was available to meet working capital needs, until such time as funds
were available from the sale of the Gisborne Manufacturing facility. The funds from both sources would
provide the Company with time to consider its broader capital raising requirements, which is likely to provide
all shareholders with the ability to participate.
The Board engaged with its significant shareholders to provide funding support for the Placement and made
the allocations based on appetite and ability to execute within the required timeframe.

ENDS  
 
The person who authorised this announcement:
Paul Naske
Chief Executive Officer
paul.naske@ruabio.com
+64 21 445154